Weight-Loss Stocks

Biotech

Altimmune (ALT) Stock Soars 27%: Phase 2 Data on Obesity Drug Ignites Market Optimism

In a remarkable turn of events, Altimmune (NASDAQ: ALT) witnessed a staggering 27% surge in its stock price this morning,…

Read More »
Biotech

Structure Therapeutics’ Surge in Pre-Market Trading: A Deep Dive

Structure Therapeutics (NASDAQ: GPCR) has seen a significant surge in pre-market trading, driven by several key factors that have captivated…

Read More »
Consumer

ELEVAI Skincare CEO to Present at Beauty Through Science Conference in Stockholm, Sweden

ELEVAI Labs (NASDAQ: ELAB), a pioneering force in medical aesthetics, announced that Chief Executive Officer Jordan R. Plews, PhD has…

Read More »
Biotech

ELEVAI Biosciences CEO to Showcase Company’s Obesity and Muscle Loss Prevention Technology at UCLA LA-BEST 2024 Conference

ELEVAI Labs (NASDAQ: ELAB), a pioneering force in medical aesthetics, announced that Chief Executive Officer Dr. Jordan R. Plews, PhD…

Read More »
Featured

ELEVAI Labs: A Strategic Expansion in Biosciences and Skincare

ELEVAI Labs (NASDAQ: ELAB), a pioneering force in medical aesthetics, has made significant strides of late with the launch of…

Read More »
Top Stories

Elon Musk Praises Novo Nordisk’s Weight-Loss Drug Ozempic as Solution to Childhood Obesity Epidemic

Tesla (NASDAQ: TSLA) and SpaceX CEO Elon Musk has sparked a conversation about childhood obesity and potential solutions after giving…

Read More »
Biotech

ELEVAI Labs Acquires Exclusive License to Develop and Commercialize Novel Assets to Treat Obesity and Muscle Loss Prevention

The agreement adds two drug candidates to the company’s product pipeline, “EL-22”, a clinical-stage engineered probiotic expressing myostatin, and “EL-32”,…

Read More »
Featured

Global Obesity Drug Market to Grow 16x – Top Weight-Loss Stocks to Watch in 2024

With the obesity drug market poised for exponential future growth, here’s the skinny on the top obesity and weight-loss stocks…

Read More »
Back to top button